WUXIF (Wuxi AppTec Co) 3-Year Share Buyback Ratio : 0.80% (As of Mar. 2025)

View and export this data going back to 2019. Start your Free Trial

What is Wuxi AppTec Co 3-Year Share Buyback Ratio?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

3-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past three years. It is calculated as the annualized percentage change in shares outstanding from three years ago to the current year. A positive ratio may indicate share buybacks over the period, while a zero or negative ratio may reflect no repurchases or potential share issuance. Wuxi AppTec Co's current 3-Year Share Buyback Ratio was 0.80%.

The historical rank and industry rank for Wuxi AppTec Co's 3-Year Share Buyback Ratio or its related term are showing as below:

WUXIF' s 3-Year Share Buyback Ratio Range Over the Past 10 Years
Min: -9.9 Med: -2.4 Max: 0.8
Current: 0.8

During the past 11 years, Wuxi AppTec Co's highest 3-Year Share Buyback Ratio was 0.80%. The lowest was -9.90%. And the median was -2.40%.

WUXIF's 3-Year Share Buyback Ratio is ranked better than
89.07% of 183 companies
in the Medical Diagnostics & Research industry
Industry Median: -3 vs WUXIF: 0.80

Competitive Comparison of Wuxi AppTec Co's 3-Year Share Buyback Ratio

For the Diagnostics & Research subindustry, Wuxi AppTec Co's 3-Year Share Buyback Ratio, along with its competitors' market caps and 3-Year Share Buyback Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Wuxi AppTec Co's 3-Year Share Buyback Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Wuxi AppTec Co's 3-Year Share Buyback Ratio distribution charts can be found below:

* The bar in red indicates where Wuxi AppTec Co's 3-Year Share Buyback Ratio falls into.

Save Embed

;

Save Embed

;

Wuxi AppTec Co 3-Year Share Buyback Ratio Calculation

This is the annualized percentage change in shares outstanding from three years ago to the current year. The annualized percentage change is calculated with expontential compound based on the latest four years of annual data on Shares Outstanding (EOP).

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

Wuxi AppTec Co (OTCPK:WUXIF) 3-Year Share Buyback Ratio Explanation

A negative number means the company might be issuing new shares. A positive number indicates that the company is buying back shares.

Be Aware

Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.

Wuxi AppTec Co 3-Year Share Buyback Ratio Related Terms

Thank you for viewing the detailed overview of Wuxi AppTec Co's 3-Year Share Buyback Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Wuxi AppTec Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Wuxi AppTec Co Ltd (OTCPK:WUXIF) » Definitions » 3-Year Share Buyback Ratio

Comparable Companies

Traded in Other Exchanges

WUXAY:USA 02359:Hong Kong WX8:Germany 603259:China

Address

288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Pudong New Area, Shanghai, CHN, 200131

Website

https://www.wuxiapptec.com

Wuxi AppTec Co Ltd provides a portfolio of research and manufacturing services throughout the discovery, development, and manufacturing spectrum for small molecule drugs, development of computer software and databases as well as consulting services for combinatorial chemistry and pharmaceuticals. The services offered by the company include drug research and development testing, clinical research services, an end-to-end CRDMO platform for peptide, oligonucleotide, and small molecules, and integrated biology services and solutions for drug discovery. The company's reportable segments are WuXi Chemistry, which derives maximum revenue, WuXi Testing, WuXi Biology, and Others. Geographically, it derives key revenue from the United States of America, followed by China, Europe, and other regions.